Expertise in
7
conditions

Simon F. Rinaldi

Oxford, ENG, GB 
Expertise in
7
conditions
Oxford, ENG, GB 

Overview

Simon Rinaldi practices practicing medicine in Oxford, United Kingdom.

Mr. Rinaldi is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Miller-Fisher Syndrome, and ADULT Syndrome.

He is actively involved in clinical research, co-authoring 69 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Oxford, ENG, United Kingdom
Other Locations
Radcliffe On Trent, ENG, United Kingdom
London, ENG, United Kingdom
Edinburgh, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Dundee, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open-label, Single Arm, Multi-centre, Phase II Study Investigating Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of Imlifidase in Patients With Guillain-Barré Syndrome, in Comparison With Matched Control Patients
An Open-label, Single Arm, Multi-centre, Phase II Study Investigating Safety, Tolerability, Efficacy, Pharmacodynamics and Pharmacokinetics of Imlifidase in Patients With Guillain-Barré Syndrome, in Comparison With Matched Control Patients
Enrollment Status: Completed
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drug: Imlifidase
Study Phase: Phase 2
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
Enrollment Status: Completed
Publish Date: December 12, 2024
View 1 Less Clinical Trial

69 Total Publications

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.
Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 23, 2026

Frequently Asked Questions about Simon F. Rinaldi

Is Simon F. Rinaldi a top-rated expert for Guillain-Barre Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Simon F. Rinaldi is classified as an Elite expert for Guillain-Barre Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Simon F. Rinaldi participate in research or clinical trials?

Yes. Simon F. Rinaldi has published 69 articles and abstracts on conditions like Guillain-Barre Syndrome. You can view a list of Simon F. Rinaldi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rinaldi's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile